![June Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
June Lee è nel consiglio di amministrazione di Eledon Pharmaceuticals, Inc. e presidente del Council of Korean Americans. Nella sua carriera passata ha occupato la posizione di Chief Development Officer & Executive VP presso MyoKardia, Inc, Medical Director di Genentech, Inc, Director-Translational Research & Catalyst Program presso The University of California, San Francisco e Professor presso la California University of Science & Medicine. June Lee ha conseguito una laurea presso la Johns Hopkins University School of Medicine e un dottorato presso la UC Davis School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 28/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
ABIVAX SA -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 09/12/2020 |
| TENAYA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/11/2021 |
| ABIVAX | Direttore/Membro del Consiglio | 11/07/2023 |
| NKGEN BIOTECH KOREA CO., LTD. | Direttore/Membro del Consiglio | 21/11/2025 |
Council of Korean Americans | Direttore/Membro del Consiglio | - |
GenEdit, Inc.
 GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Direttore/Membro del Consiglio | - |
University of California Drug Discovery Consortium | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Investitore di Private Equity | 30/11/2024 |
| CINCOR PHARMA, INC. | Direttore/Membro del Consiglio | 24/02/2023 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
UC Davis School of Medicine
 UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
UCSF School of Medicine
 UCSF School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Council of Korean Americans | |
NKMAX Co., Ltd. (South korea)
 NKMAX Co., Ltd. (South korea) BiotechnologyHealth Technology Manufactures biological products | Health Technology |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Health Technology |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
University of California Drug Discovery Consortium |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
